These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 2110366

  • 1. Amino acid residues that affect interaction of tissue-type plasminogen activator with plasminogen activator inhibitor 1.
    Madison EL, Goldsmith EJ, Gerard RD, Gething MJ, Sambrook JF, Bassel-Duby RS.
    Proc Natl Acad Sci U S A; 1990 May; 87(9):3530-3. PubMed ID: 2110366
    [Abstract] [Full Text] [Related]

  • 2. Serpin-resistant mutants of human tissue-type plasminogen activator.
    Madison EL, Goldsmith EJ, Gerard RD, Gething MJ, Sambrook JF.
    Nature; 1989 Jun 29; 339(6227):721-4. PubMed ID: 2500599
    [Abstract] [Full Text] [Related]

  • 3. Variants of tissue-type plasminogen activator that display extraordinary resistance to inhibition by the serpin plasminogen activator inhibitor type 1.
    Tachias K, Madison EL.
    J Biol Chem; 1997 Jun 06; 272(23):14580-5. PubMed ID: 9169416
    [Abstract] [Full Text] [Related]

  • 4. The variable region-1 from tissue-type plasminogen activator confers specificity for plasminogen activator inhibitor-1 to thrombin by facilitating catalysis: release of a kinetic block by a heterologous protein surface loop.
    Dekker RJ, Eichinger A, Stoop AA, Bode W, Pannekoek H, Horrevoets AJ.
    J Mol Biol; 1999 Oct 29; 293(3):613-27. PubMed ID: 10543954
    [Abstract] [Full Text] [Related]

  • 5. Restoration of serine protease-inhibitor interaction by protein engineering.
    Madison EL, Goldsmith EJ, Gething MJ, Sambrook JF, Gerard RD.
    J Biol Chem; 1990 Dec 15; 265(35):21423-6. PubMed ID: 2123870
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Binding of tissue-type plasminogen activator with human endothelial cell monolayers. Characterization of the high affinity interaction with plasminogen activator inhibitor-1.
    Russell ME, Quertermous T, Declerck PJ, Collen D, Haber E, Homcy CJ.
    J Biol Chem; 1990 Feb 15; 265(5):2569-75. PubMed ID: 2105930
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The interaction of plasminogen activator inhibitor 1 with plasminogen activators (tissue-type and urokinase-type) and fibrin: localization of interaction sites and physiologic relevance.
    Keijer J, Linders M, van Zonneveld AJ, Ehrlich HJ, de Boer JP, Pannekoek H.
    Blood; 1991 Jul 15; 78(2):401-9. PubMed ID: 1712649
    [Abstract] [Full Text] [Related]

  • 15. Artificial exon shuffling between tissue-type plasminogen activator (t-PA) and urokinase (u-PA): a comparative study on the fibrinolytic properties of t-PA/u-PA hybrid proteins.
    de Vries C, Veerman H, Blasi F, Pannekoek H.
    Biochemistry; 1988 Apr 05; 27(7):2565-72. PubMed ID: 3132969
    [Abstract] [Full Text] [Related]

  • 16. Plasminogen activator inhibitor 1 contains a cryptic high affinity receptor binding site that is exposed upon complex formation with tissue-type plasminogen activator.
    Horn IR, van den Berg BM, Moestrup SK, Pannekoek H, van Zonneveld AJ.
    Thromb Haemost; 1998 Nov 05; 80(5):822-8. PubMed ID: 9843178
    [Abstract] [Full Text] [Related]

  • 17. Elucidation of the structural basis for the slow reactivity of thrombin with plasminogen activator inhibitor-1.
    Rezaie AR.
    Biochemistry; 1998 Sep 22; 37(38):13138-42. PubMed ID: 9748320
    [Abstract] [Full Text] [Related]

  • 18. Characterization of interaction of active-site serine mutants of tissue-type plasminogen activator with plasminogen activator inhibitor-1.
    Monge JC, Lucore CL, Fry ET, Sobel BE, Billadello JJ.
    J Biol Chem; 1989 Jun 25; 264(18):10922-5. PubMed ID: 2499585
    [Abstract] [Full Text] [Related]

  • 19. Structure-function studies of the SERPIN plasminogen activator inhibitor type 1. Analysis of chimeric strained loop mutants.
    Lawrence DA, Strandberg L, Ericson J, Ny T.
    J Biol Chem; 1990 Nov 25; 265(33):20293-301. PubMed ID: 1700786
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.